ICON Shares Down 50% After Accounting Probe as Jefferies Upgrades to Buy with $135 Target
Shares have plunged nearly 50% over the past year and 45% year-to-date after an internal accounting investigation. Jefferies upgraded the stock from Hold to Buy with a reduced $135 target, while TD Cowen trimmed 2026 revenue estimates by 2% and forecast a 14% EPS hit in 2026-27.
1. Jefferies Upgrades to Buy with $135 Target
Jefferies upgraded the stock from Hold to Buy and set a new price target of $135 after the share price declined nearly 50% over one year. The firm argues that current valuations are attractive despite potential AI-driven pressure on clinical research services.
2. Accounting Investigation Spurs Share Slump
An internal accounting probe has driven shares down 45% year-to-date and 50% over the past year, raising concerns about financial governance. Company management insists the investigation will not materially impact revenue and is focused on strengthening internal controls.
3. TD Cowen Trims Estimates, Minimizes Impact
TD Cowen reduced its 2026 revenue forecast by just 2% and projects a 14% adjusted EPS decline in 2026 and 2027, signaling confidence in the business’s underlying resilience. Analysts view these modest cuts as evidence that financial fallout from the probe will be contained.